BREXIT: Continuity supply of medicines and medical products


As a result of the UK entering a transition period with the EU from the 1 February 2020 to 31 December 2020, McKesson UK wanted to take the opportunity to update you on our Brexit contingency planning.


Further to a letter published by the Department of Health and Social Care on 31 January 202, the Department has confirmed that it is now standing down its continuity of supply plans and preparation for EU exit. During the transition period, the UK will continue to stay aligned with EU law, and supplies including medicines and medical goods, will continue to flow as they do today.


During the transition period McKesson UK’s cross functional contingency planning team will continue to monitor the external environment an remain closely aligned to the DHSC, the NHS and all our trade bodies to ensure that our efforts remain focused on working to deliver a service in which patients receive the right medicines, in the right place at the right time.


The transition period, now the UK has left the EU


There is now a transition period until the end of 2020 while the UK and EU negotiate additional arrangements. The current rules on trade, travel, and business for the UK and EU will continue to apply during the transition period. New rules will take effect on 1 January 2021.


For information and updates please visit the government website.